Sleep Disorder Connect
  • Saved
Patient experience with idiopathic hypersomnia | NSS

Patient experience with idiopathic hypersomnia | NSS

Source : https://www.dovepress.com/symptom-severity-and-treatment-satisfaction-in-patients-with-idiopathi-peer-reviewed-fulltext-article-NSS

Idiopathic hypersomnia is a disabling neurologic sleep disorder with no known cause. People with this disorder are extremely sleepy during the day and often need to sleep for long amounts...

Conclusion: Overall, participants with idiopathic hypersomnia, with or without LST, had substantial symptom burden despite most of the study population taking off-label medications and using nonprescription measures to manage symptoms.

  • Saved
The Comparative Effectiveness and Safety of Insomnia Drugs: A Systematic Review and Network Meta-Analysis of 153 Randomized Trials - Drugs

The Comparative Effectiveness and Safety of Insomnia Drugs: A Systematic Review and Network Meta-Analysis of 153 Randomized Trials - Drugs

Source : https://link.springer.com/article/10.1007/s40265-023-01859-8

Background Pharmacological treatment is common in practice and widely used for the management of insomnia. However, evidence comparing the relative effectiveness, safety, and certainty of evidence among drug classes and...

Conclusions: Non-benzodiazepines probably improve total sleep time, sleep onset latency, and wake time after sleep onset. Other insomnia drug classes and individual drugs also showed potential benefits in improving insomnia symptoms. However, the choice of insomnia drugs should be based on the phenotype of insomnia presented, as well as each...

  • Saved
Orexin 2 receptor-selective agonist danavorexton (TAK-925) promotes wakefulness in non-human primates and healthy individuals - PubMed

Orexin 2 receptor-selective agonist danavorexton (TAK-925) promotes wakefulness in non-human primates and healthy individuals - PubMed

Source : https://pubmed.ncbi.nlm.nih.gov/36934366/

The orexin 2 receptor-selective agonist danavorexton (TAK-925) has been shown to produce wake-promoting effects in wild-type mice, narcolepsy-model mice, and individuals with narcolepsy type 1 and type 2. Here, we...

Conclusions/Relevance: Together, these results indicate that an orexin 2 receptor agonist increases wakefulness in non-human primates and healthy individuals during their sleep phase.

  • Saved
The orexinergic system mediates the excitatory effects of caffeine on the arousal and sympathetic activity

The orexinergic system mediates the excitatory effects of caffeine on the arousal and sympathetic activity

Source : https://www.cell.com/heliyon/fulltext/S2405-8440(23)01377-4?_returnURL=https://linkinghub.elsevier.com/retrieve/pii/S2405844023013774?showall=true

Caffeine is a non-selective adenosine receptor antagonist with pro-arousal and pro-sympathetic nervous system excitatory effects, and these pharmacological effects fit well with the physiological functions of orexin. The purpose of...

Conclusions: Orexinergic nervous system mediated caffeine's excitatory effects on the pro-arousal and pro-sympathetic nervous systems. Orexin is likely to be an important performer in the pharmacological effects of caffeine.

  • Saved
Physicians' attitudes toward hypnotics for insomnia: A questionnaire-based study - PubMed

Physicians' attitudes toward hypnotics for insomnia: A questionnaire-based study - PubMed

Source : https://pubmed.ncbi.nlm.nih.gov/36865069/

The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site. The site is secure....

Discussion: This study suggested that physicians believed ORA to be an effective and safe hypnotic and were compelled to prescribe benzodiazepine and non-benzodiazepine frequently, choosing efficacy over safety.